Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation

BackgroundThe assessment of cell-free circulating DNA fragments, also known as a "liquid biopsy" of the patient's plasma, is an important source for the discovery and subsequent non-invasive monitoring of cancer and other pathological conditions. Although the nucleosome-guided fragmentation patterns of cell-free DNA (cfDNA) have not yet been studied in detail, non-random representation of cfDNA sequencies may reflect chromatin features in the tissue of origin at gene-regulation level.ResultsIn this study, we investigated the association between epigenetic landscapes of human tissues evident in the patterns of cfDNA in plasma by deep sequencing of human cfDNA samples. We have demonstrated that baseline characteristics of cfDNA fragmentation pattern are in concordance with the ones corresponding to cell lines-derived. To identify the loci differentially represented in cfDNA fragment, we mapped the transcription start sites within the sequenced cfDNA fragments and tested for association of these genomic coordinates with the relative strength and the patterns of gene expressions. Preselected sets of house-keeping and tissue specific genes were used as models for actively expressed and silenced genes. Developed measure of gene regulation was able to differentiate these two sets based on sequencing coverage near gene transcription start site.ConclusionExperimental outcomes suggest that cfDNA retains characteristics previously noted in genome-wide analysis of chromatin structure, in particular, in MNase-seq assays. Thus far the analysis of the DNA fragmentation pattern may aid further developing of cfDNA based biomarkers for a variety of human conditions.

[1]  R. Chalkley,et al.  Analysis of the competition between nucleosome formation and transcription factor binding. , 1994, The Journal of biological chemistry.

[2]  Dustin E. Schones,et al.  Dynamic Regulation of Nucleosome Positioning in the Human Genome , 2008, Cell.

[3]  M. Sikorska,et al.  Measurement of apoptosis by DNA fragmentation. , 2004, Methods in molecular biology.

[4]  A. Giuliano,et al.  Prediction of breast tumor progression by integrity of free circulating DNA in serum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Steven Gray,et al.  Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. , 2012, Lung cancer.

[6]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[7]  Steven M. Johnson,et al.  Determinants of nucleosome organization in primary human cells , 2011, Nature.

[8]  Y. Higuchi.  Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. , 2003, Biochemical pharmacology.

[9]  Xiu-juan Zhao,et al.  Nucleosome Organization around Pseudogenes in the Human Genome , 2015, BioMed research international.

[10]  Nicholas J. Wang,et al.  Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease , 2015, PloS one.

[11]  A. Rafii,et al.  [Circulating tumor cells: cornerstone of personalized medicine]. , 2014, Journal de gynecologie, obstetrique et biologie de la reproduction.

[12]  Vishwanath R Iyer,et al.  Nucleosome positioning: bringing order to the eukaryotic genome. , 2012, Trends in cell biology.

[13]  J. Soria,et al.  Circulating Tumor Cells in Lung Cancer , 2012, Acta Cytologica.

[14]  T. Richmond,et al.  The structure of DNA in the nucleosome core , 2003, Nature.

[15]  M. Škoberne,et al.  Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. , 2003, Croatian medical journal.

[16]  V. Wong,et al.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.

[17]  S. Jacobsen,et al.  Nucleosome Organization in Human Embryonic Stem Cells , 2015, PloS one.

[18]  L. Burgoyne,et al.  Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. , 1973, Biochemical and biophysical research communications.

[19]  A. Rafii,et al.  Cellules tumorales circulantes : pierre angulaire de la médecine personnalisée , 2014 .

[20]  Yama W. L. Zheng,et al.  Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. , 2012, Clinical chemistry.

[21]  N. Barkai,et al.  Two strategies for gene regulation by promoter nucleosomes. , 2008, Genome research.

[22]  T. Fennell,et al.  Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries , 2011, Genome Biology.

[23]  D. MacAlpine,et al.  Chromatin and DNA replication. , 2013, Cold Spring Harbor perspectives in biology.

[24]  Steven Henikoff,et al.  Nucleosome destabilization in the epigenetic regulation of gene expression , 2008, Nature Reviews Genetics.

[25]  J. Cidlowski,et al.  Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases , 1997, Cell Death and Differentiation.

[26]  N. Thorne,et al.  High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA , 2015, BMC Medical Genomics.

[27]  K. Park,et al.  Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer. , 2012, Anticancer research.

[28]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[29]  Sanghee Kim,et al.  Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection , 2014, Annals of surgical treatment and research.

[30]  Peter Ulz,et al.  Circulating tumor DNA as a liquid biopsy for cancer. , 2015, Clinical chemistry.

[31]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[32]  Steven M. Johnson,et al.  A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. , 2008, Genome research.

[33]  H. Schwarzenbach.  Circulating nucleic acids as biomarkers in breast cancer , 2013, Breast Cancer Research.

[34]  Z. Xuan,et al.  Genome-wide in situ exon capture for selective resequencing , 2007, Nature Genetics.

[35]  Vasily M Studitsky,et al.  Nature of the nucleosomal barrier to RNA polymerase II. , 2005, Molecular cell.

[36]  A. Giglio,et al.  Characterization of cell-free circulating DNA in plasma in patients with prostate cancer , 2013, Tumor Biology.

[37]  Weina Fu,et al.  Nucleosome Positioning with Set of Key Positions and Nucleosome Affinity , 2014, The open biomedical engineering journal.

[38]  Yuriy L. Orlov,et al.  Blurring of High-Resolution Data Shows that the Effect of Intrinsic Nucleosome Occupancy on Transcription Factor Binding is Mostly Regional, Not Local , 2010, PLoS Comput. Biol..

[39]  H. Szerlong,et al.  Nucleosome distribution and linker DNA: connecting nuclear function to dynamic chromatin structure. , 2011, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[40]  S. Orrenius,et al.  Assessment of Apoptosis and Necrosis by DNA Fragmentation and Morphological Criteria , 2001, Current protocols in cell biology.